Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 34c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q1 EPS of ($0.47), $0.34 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• iMetal Resources closes $3M private placement with McFarlane Lake